ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
samfiodiving
|
102 |
25K |
9 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
25K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
samfiodiving
|
102 |
25K |
18 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
25K
|
18
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
5 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
6 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
3 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
5 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
7 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
851
|
206K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
5 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
851
|
206K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
8 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
8
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
7 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
4 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
11 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
11
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
14 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
851
|
206K
|
14
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
3 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
851
|
206K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
6 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
851
|
206K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
851
|
206K
|
6
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
851
|
206K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
11 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
851
|
206K
|
11
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
851
|
206K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
851
|
206K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
samfiodiving
|
851 |
206K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
851
|
206K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax incentive payment
|
|
samfiodiving
|
34 |
9.5K |
9 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
34
|
9.5K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax incentive payment
|
|
samfiodiving
|
34 |
9.5K |
7 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
34
|
9.5K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Receipt of R&D Tax incentive payment
|
|
samfiodiving
|
34 |
9.5K |
7 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
34
|
9.5K
|
7
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
10 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
39K
|
10
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
3 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
39K
|
3
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
5 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
39K
|
5
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
9 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
161
|
39K
|
9
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
3 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
39K
|
3
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
2 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
39K
|
2
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
5 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
39K
|
5
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
6 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
39K
|
6
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
4 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
4
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
15 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
15
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
3
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
0
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
5
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
0 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
0
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
samfiodiving
|
161 |
39K |
10 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
161
|
39K
|
10
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
samfiodiving
|
32K |
16M |
62 |
04/01/24 |
04/01/24 |
Charts
|
32K
|
16M
|
62
|
|
ASX - By Stock
|
VML Mining |
Re:
VML General Comments - Chat
|
|
samfiodiving
|
8.3K |
3.6M |
7 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
8.3K
|
3.6M
|
7
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
samfiodiving
|
43 |
13K |
1 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
43
|
13K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
samfiodiving
|
43 |
13K |
3 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
43
|
13K
|
3
|
|
ASX - By Stock
|
VML Mining |
Re:
VML General Comments - Chat
|
|
samfiodiving
|
8.3K |
3.6M |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
8.3K
|
3.6M
|
5
|
|
ASX - By Stock
|
VML Mining |
Re:
VML General Comments - Chat
|
|
samfiodiving
|
8.3K |
3.6M |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
8.3K
|
3.6M
|
5
|
|